<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ferrer I</submitter><funding>La Caixa Foundation</funding><funding>Instituto de Salud Carlos III</funding><pagination>6427</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9223516</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(12)</volume><pubmed_abstract>Altered protein phosphorylation is a major pathologic modification in tauopathies and Alzheimer's disease (AD) linked to abnormal tau fibrillar deposits in neurofibrillary tangles (NFTs) and pre-tangles and β-amyloid deposits in AD. hTau transgenic mice, which express 3R and less 4R human tau with no mutations in a murine knock-out background, show increased tau deposition in neurons but not NFTs and pre-tangles at the age of nine months. Label-free (phospho)proteomics and SWATH-MS identified 2065 proteins in hTau and wild-type (WT) mice. Only six proteins showed increased levels in hTau; no proteins were down-regulated. Increased tau phosphorylation in hTau was detected at Ser199, Ser202, Ser214, Ser396, Ser400, Thr403, Ser404, Ser413, Ser416, Ser422, Ser491, and Ser494, in addition to Th</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.</pubmed_title><pmcid>PMC9223516</pmcid><funding_grant_id>PT17/0019/009</funding_grant_id><funding_grant_id>LCF/PR/HR19/52160007</funding_grant_id><pubmed_authors>Ferrer I</pubmed_authors><pubmed_authors>Cartas-Cejudo P</pubmed_authors><pubmed_authors>Lachen-Montes M</pubmed_authors><pubmed_authors>Del Rio JA</pubmed_authors><pubmed_authors>Fernandez-Irigoyen J</pubmed_authors><pubmed_authors>Santamaria E</pubmed_authors><pubmed_authors>Ausin K</pubmed_authors><pubmed_authors>Andres-Benito P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.</name><description>Altered protein phosphorylation is a major pathologic modification in tauopathies and Alzheimer's disease (AD) linked to abnormal tau fibrillar deposits in neurofibrillary tangles (NFTs) and pre-tangles and β-amyloid deposits in AD. hTau transgenic mice, which express 3R and less 4R human tau with no mutations in a murine knock-out background, show increased tau deposition in neurons but not NFTs and pre-tangles at the age of nine months. Label-free (phospho)proteomics and SWATH-MS identified 2065 proteins in hTau and wild-type (WT) mice. Only six proteins showed increased levels in hTau; no proteins were down-regulated. Increased tau phosphorylation in hTau was detected at Ser199, Ser202, Ser214, Ser396, Ser400, Thr403, Ser404, Ser413, Ser416, Ser422, Ser491, and Ser494, in addition to Th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-04T08:48:11.059Z</modification><creation>2025-04-04T08:48:11.059Z</creation></dates><accession>S-EPMC9223516</accession><cross_references><pubmed>35742871</pubmed><doi>10.3390/ijms23126427</doi></cross_references></HashMap>